G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,333,117 | -32.4% | 925,776 | +16.9% | 0.00% | -50.0% |
Q2 2023 | $1,972,364 | -1.5% | 792,114 | +6.0% | 0.00% | 0.0% |
Q1 2023 | $2,003,061 | -26.1% | 747,411 | +49.8% | 0.00% | 0.0% |
Q4 2022 | $2,709,043 | -54.8% | 498,903 | +4.0% | 0.00% | -66.7% |
Q3 2022 | $5,991,000 | +176.8% | 479,635 | +9.5% | 0.01% | +200.0% |
Q2 2022 | $2,164,000 | -28.4% | 438,156 | +10.1% | 0.00% | -33.3% |
Q1 2022 | $3,024,000 | +28.0% | 397,879 | +72.0% | 0.00% | +50.0% |
Q4 2021 | $2,362,000 | +30.6% | 231,315 | +71.7% | 0.00% | 0.0% |
Q3 2021 | $1,808,000 | -37.9% | 134,739 | +1.6% | 0.00% | -33.3% |
Q2 2021 | $2,910,000 | -1.4% | 132,648 | -0.7% | 0.00% | 0.0% |
Q1 2021 | $2,950,000 | +13.1% | 133,520 | -7.9% | 0.00% | 0.0% |
Q4 2020 | $2,608,000 | +37.3% | 144,953 | -11.9% | 0.00% | +50.0% |
Q3 2020 | $1,900,000 | -48.7% | 164,517 | +7.7% | 0.00% | -60.0% |
Q2 2020 | $3,707,000 | +2889.5% | 152,788 | +1253.9% | 0.01% | – |
Q1 2020 | $124,000 | -46.8% | 11,285 | +28.0% | 0.00% | – |
Q4 2019 | $233,000 | – | 8,819 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
Birchview Capital, LP | 40,000 | $217 | 0.15% |
XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |